The Corporate Advisory Team
PharmaVentures' Corporate Advisory team has a broad range of experiences covering multiple sectors of the pharmaceutical and biotechnology industries.
Andrew Lomas PhD Advisor
Andrew has considerable technical expertise in the fields of drug discovery and development in general, and oncology in particular. After taking an MSc in medicinal chemistry at the University of Oxford, Andrew stayed at Oxford as a tutor in organic and medicinal chemistry and completed a Doctorate in pharmacology/molecular oncology under the supervision of Prof Adrian Harris at the Institute of Molecular Medicine. Andrew works within the Corporate Advisory team specialising in benchmarking, product and technology valuations, and litigation support.